4//SEC Filing
Novo Holdings A/S 4
Accession 0001388325-25-000018
CIK 0001770069other
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 4:31 PM ET
Size
11.3 KB
Accession
0001388325-25-000018
Insider Transaction Report
Form 4
Novo A/S
10% Owner
Transactions
- Conversion
Voting Common Stock
2025-10-28+2,733,681→ 2,733,681 total - Conversion
Series D Preferred Stock
2025-10-28−19,734,671→ 0 total→ Voting Common Stock (1,174,682 underlying) - Purchase
Voting Common Stock
2025-10-28$17.00/sh+952,941$16,199,997→ 3,686,622 total - Conversion
Series C Preferred Stock
2025-10-28−26,191,207→ 0 total→ Voting Common Stock (1,558,999 underlying)
Footnotes (2)
- [F1]The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- [F2]Represents a purchase from the underwriters in the Issuer's initial public offering.
Documents
Issuer
MapLight Therapeutics, Inc.
CIK 0001770069
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001388325
Filing Metadata
- Form type
- 4
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 30, 4:31 PM ET
- Size
- 11.3 KB